Related Experiment Video
Updated: Jun 20, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebral microbleeds predict first-ever symptomatic cerebrovascular events
Tomofumi Nishikawa1, Tetsuya Ueba, Motohiro Kajiwara
1Department of Neurosurgery, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada, Osaka 596-8501, Japan.
Objective:
Cerebral microbleeds (CMB) on gradient-echo T2*-weighted magnetic resonance image (MRI) are frequently seen in patients with cerebral diseases. In this observational study we assessed whether CMB are a predictive factor for first-ever cerebrovascular events.
Patients And Methods:
This study consisted of 698 subjects without a history of symptomatic cerebrovascular events, who received gradient-echo T2*-weighted MRI for 3 months between November 2003 and January 2004 in Kishiwada City Hospital, Osaka, Japan. These subjects were then observed as outpatients for over 3.5 years.
Results:
The prevalence of CMB at baseline was 17.0% (119/698) in this population, and the follow-up rate was 51%. A total of 36 first-ever symptomatic cerebrovascular events were observed during the 3 and a half-year follow-up period. First-ever symptomatic cerebrovascular events occurred significantly more frequently in subjects with CMB (15 cases) than those without CMB (21 cases) (p=0.001). Even after adjusting for age, sex and hypertension, it was revealed that the presence of CMB was an independent predictor for the first-ever symptomatic cerebrovascular event by using the Cox proportional hazards model (hazard ratio, 2.87; 95% CI, 1.27-6.48; p=0.01).
Conclusion:
The presence of CMB is an independent predictor of first-ever symptomatic cerebrovascular diseases.
Insights
Cerebral microbleeds (CMB) detected by MRI are a significant predictor of future cerebrovascular events. Identifying CMB can help assess stroke risk in patients with neurological conditions.
Area of Science:
- Neurology
- Radiology
- Epidemiology
Background:
- Cerebral microbleeds (CMB) are common findings in neuroimaging, particularly in patients with various cerebral diseases.
- Gradient-echo T2*-weighted MRI is a key technique for detecting CMB.
Purpose of the Study:
- To investigate whether cerebral microbleeds (CMB) serve as a predictive factor for first-ever cerebrovascular events.
- To assess the independent predictive value of CMB for incident cerebrovascular events.
Main Methods:
- An observational study involving 698 subjects without prior cerebrovascular events.
- Gradient-echo T2*-weighted MRI was performed, followed by an average 3.5-year outpatient observation period.
Main Results:
- The prevalence of CMB at baseline was 17.0%.
- First-ever symptomatic cerebrovascular events occurred significantly more frequently in subjects with CMB (15 cases) compared to those without (21 cases).
- CMB were identified as an independent predictor of first-ever symptomatic cerebrovascular events (HR, 2.87; 95% CI, 1.27-6.48) after adjusting for age, sex, and hypertension.
Conclusions:
- The presence of cerebral microbleeds (CMB) is an independent predictor of first-ever symptomatic cerebrovascular diseases.
- MRI-detected CMB can aid in risk stratification for cerebrovascular events.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Cerebral Edema l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies

